Nicole Ackermans

Nicole Ackermans, a clinician-scientist and communicator, dives into groundbreaking developments in gene therapy for Huntington's disease. She discusses a trial showing a significant 75% slowdown in disease progression, explaining the innovative surgery and viral delivery technique used. The conversation also touches on the next steps for larger trials, challenges regarding accessibility, and the potential of treating patients before symptoms appear. Ackermans sheds light on the complex interplay between cutting-edge science and real-world applications.